Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steady-state telithromycin pharmacokinetics in adults with acute exacerbation of chronic obstructive pulmonary disease
2006-003886-15Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jan 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of telithromycin in chronic obstructive pulmonary disease (COPD), sponsored by Sanofi. Primary endpoint: Steady-state plasma pharmacokinetic evaluation of telithromycin. Started Jan 2007; status: terminated.
02
Drugs
telithromycin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2006-003886-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003886-15.